Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner
Cancers · 04.05.2023 · 15 (9) · 2601
DOI: 10.3390/cancers15092601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 04.05.2023. Verfasst von Hannah K Jackson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, U…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: James Tudor Fund, Haydn Green Institute for Innovation and Entrepreneurshi, Stoneygate Trust.
Abstract (Originalsprache)
Extracellular vesicles (EVs) have emerged as pivotal mediators of communication in the tumour microenvironment. More specifically, nanosized extracellular vesicles termed exosomes have been shown to contribute to the establishment of a premetastatic niche. Here, we sought to determine what role exosomes play in medulloblastoma (MB) progression and elucidate the underlying mechanisms. Metastatic MB cells (D458 and CHLA-01R) were found to secrete markedly more exosomes compared to their nonmetastatic, primary counterparts (D425 and CHLA-01). In addition, metastatic cell-derived exosomes significantly enhanced the migration and invasiveness of primary MB cells in transwell migration assays. Protease microarray analysis identified that matrix metalloproteinase-2 (MMP-2) was enriched in metastatic cells, and zymography and flow cytometry assays of metastatic exosomes demonstrated higher levels of functionally active MMP-2 on their external surface. Stable genetic knockdown of MMP-2 or extracellular matrix metalloproteinase inducer (EMMPRIN) in metastatic MB cells resulted in the loss of this promigratory effect. Analysis of serial patient cerebrospinal fluid (CSF) samples showed an increase in MMP-2 activity in three out of four patients as the tumour progressed. This study demonstrates the importance of EMMPRIN and MMP-2-associated exosomes in creating a favourable environment to drive medulloblastoma metastasis via extracellular matrix signalling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, UK.
- Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
- Department of Experimental Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
- Department of Neurosurgery, Nottingham University Hospital, Nottingham NG7 2UH, UK.
- School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.
ORCID-Profile: Franziska Linke, Ian D Kerr, Beth Coyle
Förderung
- James Tudor Fund
- Haydn Green Institute for Innovation and Entrepreneurshi
- Stoneygate Trust
Zitieren
APA
Jackson, H. K., Mitoko, C., Linke, F., Macarthur, D., Kerr, I. D., & Coyle, B. (2023). Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner. Cancers, 15(9), 2601. https://doi.org/10.3390/cancers15092601
Vancouver
Jackson HK, Mitoko C, Linke F, Macarthur D, Kerr ID, Coyle B. Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner. Cancers. 2023;15(9):2601. doi:10.3390/cancers15092601
BibTeX
@article{Jackson2023,
author = {Jackson, Hannah K and Mitoko, Christine and Linke, Franziska and Macarthur, Donald and Kerr, Ian D and Coyle, Beth},
title = {Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner},
journal = {Cancers},
year = {2023},
volume = {15},
number = {9},
pages = {2601},
doi = {10.3390/cancers15092601}
}
EUVIMED